Endoscopy 2007; 39(2): 106-109
DOI: 10.1055/s-2006-945107
Endoscopy essentials
© Georg Thieme Verlag KG Stuttgart · New York

Colonoscopy, tumors and inflammatory bowel disease

D.  P.  Hurlstone1
  • 1Gastroenterology and Liver Unit, Royal Hallamshire Hospital, Sheffield, UK
Further Information

Publication History

Publication Date:
27 February 2007 (online)

Changing the endoscopic paradigm for the detection, characterization and endoluminal therapy of intraepithelial neoplasia, colitis-associated cancer and inflammatory extent assessment

Previous studies have prospectively evaluated the efficacy of high-magnification chromoscopic colonoscopy (HMCC) and endoscopic mucosal resection (EMR) for the detection and treatment of sporadic adenomas and early neoplastic colorectal lesions [1]. However, the management and clinical interpretation of dysplasia in the context of chronic ulcerative colitis (CUC) is radically different to that of sporadic dysplastic lesions in the “normal” population [2] [3]. At the current time, dysplasia is the most reliable biomarker of malignant change, being present in over 70 % of CUC patients with colorectal cancer [4]. Emerging data suggest that intraepithelial neoplasia (IN) is easily missed using conventional “white light” colonoscopy and current colorectal cancer (CRC) screening protocols. Emerging data now also suggest that simple polypectomy of adenoma-like mass (ALM) may be an adequate endoluminal therapy for CRC secondary prevention in this group - a radical paradigm shift away from total colectomy [5]. Furthermore, colonoscopy with mucosal biopsy, currently considered the “gold standard” investigation for the evaluation of disease activity and extent in ulcerative colitis (an important risk factor for IN development in CUC), may now be accurately predicted in vivo using high magnification chromoscopic techniques (HMCC) [6].

References

  • 1 Hurlstone D P, Fujii T. Practical uses of chromoendoscopy and magnification at colonoscopy.  Gastrointest Endosc Clin N Am. 2005;  15 687-702
  • 2 Brostrom M O, Lofberg R, Ost A. Cancer surveillance of patients with longstanding ulcerative colitis: a clinical and endoscopical and histological study.  Gut. 1986;  27 1408-1413
  • 3 Goldmann H. Significance and detection of dysplasia in chronic colitis.  Cancer. 1996;  78 2261-2263
  • 4 Riddell R H, Goldman H, Ransohoff D F. et al . Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical implications.  Hum Pathol. 1983;  14 931-968
  • 5 Vieth M, Behrens H, Stolte M. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment.  Gut. 2006;  8 1151-1155
  • 6 Hurlstone D, Sanders D, McAlindon M. et al . High-magnification chromoscopic colonoscopy in ulcerative colitis: a valid tool for the in vivo optical biopsy and assessment of disease extent.  Endoscopy. 2006. In press; 
  • 7 Kiesslich R, Fritsch J, Holtmann M. et al . Methylene blue-aided chromoendoscopy for the detection of intraepitheial neoplasia and colon cancer in ulcerative colitis.  Gastroenterology. 2003;  124 880-888
  • 8 Hurlstone D P, Sanders D S, Lobo A J. et al . Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation.  Endoscopy. 2005;  37 1186-1192
  • 9 Connell W R, Talbot I C, Harpaz N. et al . Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.  Gut. 1994;  35 1419-1423
  • 10 Rubin P H, Friedman S, Harpaz N. et al . Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps.  Gastroenterology. 1999;  117 1295-1300
  • 11 Engelsgjerd M, Farraye F A, Odze R D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.  Gastroenterology. 1999;  117 1288-1294
  • 12 Odze R D, Farraye F A, Hecht J L, Hornick J L. Long-trem follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis.  Clin Gastroenterol Hepatol. 2004;  2 534-541
  • 13 Fujiya M, Saitoh Y, Nomura M. et al . Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis.  Gastrointest Endosc. 2002;  56 535-542
  • 14 Baron J H, Connell A M, Lennard-Jones J E. Variation between observers in describing mucosal appearances in proctocolitis.  Br Med J. 1964;  5375 89-92
  • 15 Tada M, Misaki F, Shimono M. et al . Endoscopic studies on the minute structures of colonic mucosa in the follow-up observation of ulcerative colitis.  Gastroenterol Jpn. 1978;  13 72-76
  • 16 Riley S A, Mani V, Goodman M J, Lucas S. Why do patients with ulcerative colitis relapse?.  Gut. 1990;  31 179-183
  • 17 Kiesslich R, Burg J, Vieth M. et al . Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo.  Gastroenterology. 2004;  127 706-713

D. P. Hurlstone, MD

Room BD82/B Floor, Endoscopy, Royal Hallamshire Hospital

Sheffield, S10 2JF
United Kingdom

Fax: +44-114-2712692

Email: p.hurlstone@shef.ac.uk

    >